Global Patient In-vivo Dosimetry (IVD) System Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Patient In-vivo Dosimetry (IVD) System Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Patient In-vivo Dosimetry (IVD) System by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Patient In-vivo Dosimetry (IVD) System by Country/Region, 2017, 2022 & 2028

2.2 Patient In-vivo Dosimetry (IVD) System Segment by Type

2.2.1 Portable

2.2.2 Fixed

2.3 Patient In-vivo Dosimetry (IVD) System Sales by Type

2.3.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

2.3.2 Global Patient In-vivo Dosimetry (IVD) System Revenue and Market Share by Type (2017-2022)

2.3.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Type (2017-2022)

2.4 Patient In-vivo Dosimetry (IVD) System Segment by Application

2.4.1 Medical

2.4.2 Scientific Research

2.4.3 Others

2.5 Patient In-vivo Dosimetry (IVD) System Sales by Application

2.5.1 Global Patient In-vivo Dosimetry (IVD) System Sale Market Share by Application (2017-2022)

2.5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue and Market Share by Application (2017-2022)

2.5.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Application (2017-2022)

3 Global Patient In-vivo Dosimetry (IVD) System by Company

3.1 Global Patient In-vivo Dosimetry (IVD) System Breakdown Data by Company

3.1.1 Global Patient In-vivo Dosimetry (IVD) System Annual Sales by Company (2020-2022)

3.1.2 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Company (2020-2022)

3.2 Global Patient In-vivo Dosimetry (IVD) System Annual Revenue by Company (2020-2022)

3.2.1 Global Patient In-vivo Dosimetry (IVD) System Revenue by Company (2020-2022)

3.2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company (2020-2022)

3.3 Global Patient In-vivo Dosimetry (IVD) System Sale Price by Company

3.4 Key Manufacturers Patient In-vivo Dosimetry (IVD) System Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Patient In-vivo Dosimetry (IVD) System Product Location Distribution

3.4.2 Players Patient In-vivo Dosimetry (IVD) System Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Patient In-vivo Dosimetry (IVD) System by Geographic Region

4.1 World Historic Patient In-vivo Dosimetry (IVD) System Market Size by Geographic Region (2017-2022)

4.1.1 Global Patient In-vivo Dosimetry (IVD) System Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Patient In-vivo Dosimetry (IVD) System Annual Revenue by Geographic Region

4.2 World Historic Patient In-vivo Dosimetry (IVD) System Market Size by Country/Region (2017-2022)

4.2.1 Global Patient In-vivo Dosimetry (IVD) System Annual Sales by Country/Region (2017-2022)

4.2.2 Global Patient In-vivo Dosimetry (IVD) System Annual Revenue by Country/Region

4.3 Americas Patient In-vivo Dosimetry (IVD) System Sales Growth

4.4 APAC Patient In-vivo Dosimetry (IVD) System Sales Growth

4.5 Europe Patient In-vivo Dosimetry (IVD) System Sales Growth

4.6 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Growth

5 Americas

5.1 Americas Patient In-vivo Dosimetry (IVD) System Sales by Country

5.1.1 Americas Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022)

5.1.2 Americas Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022)

5.2 Americas Patient In-vivo Dosimetry (IVD) System Sales by Type

5.3 Americas Patient In-vivo Dosimetry (IVD) System Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Patient In-vivo Dosimetry (IVD) System Sales by Region

6.1.1 APAC Patient In-vivo Dosimetry (IVD) System Sales by Region (2017-2022)

6.1.2 APAC Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2022)

6.2 APAC Patient In-vivo Dosimetry (IVD) System Sales by Type

6.3 APAC Patient In-vivo Dosimetry (IVD) System Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Patient In-vivo Dosimetry (IVD) System by Country

7.1.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022)

7.1.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022)

7.2 Europe Patient In-vivo Dosimetry (IVD) System Sales by Type

7.3 Europe Patient In-vivo Dosimetry (IVD) System Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System by Country

8.1.1 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022)

8.1.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022)

8.2 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type

8.3 Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Patient In-vivo Dosimetry (IVD) System

10.3 Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System

10.4 Industry Chain Structure of Patient In-vivo Dosimetry (IVD) System

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Patient In-vivo Dosimetry (IVD) System Distributors

11.3 Patient In-vivo Dosimetry (IVD) System Customer

12 World Forecast Review for Patient In-vivo Dosimetry (IVD) System by Geographic Region

12.1 Global Patient In-vivo Dosimetry (IVD) System Market Size Forecast by Region

12.1.1 Global Patient In-vivo Dosimetry (IVD) System Forecast by Region (2023-2028)

12.1.2 Global Patient In-vivo Dosimetry (IVD) System Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Patient In-vivo Dosimetry (IVD) System Forecast by Type

12.7 Global Patient In-vivo Dosimetry (IVD) System Forecast by Application

13 Key Players Analysis

13.1 Landauer

13.1.1 Landauer Company Information

13.1.2 Landauer Patient In-vivo Dosimetry (IVD) System Product Offered

13.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Landauer Main Business Overview

13.1.5 Landauer Latest Developments

13.2 Chiyoda Technol Corporation

13.2.1 Chiyoda Technol Corporation Company Information

13.2.2 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Offered

13.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Chiyoda Technol Corporation Main Business Overview

13.2.5 Chiyoda Technol Corporation Latest Developments

13.3 Mirion Technologies

13.3.1 Mirion Technologies Company Information

13.3.2 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Offered

13.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mirion Technologies Main Business Overview

13.3.5 Mirion Technologies Latest Developments

13.4 Thermo Fisher Scientific

13.4.1 Thermo Fisher Scientific Company Information

13.4.2 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Offered

13.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Thermo Fisher Scientific Main Business Overview

13.4.5 Thermo Fisher Scientific Latest Developments

13.5 Fuji Electric

13.5.1 Fuji Electric Company Information

13.5.2 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Offered

13.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Fuji Electric Main Business Overview

13.5.5 Fuji Electric Latest Developments

13.6 Hitachi Aloka

13.6.1 Hitachi Aloka Company Information

13.6.2 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Offered

13.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hitachi Aloka Main Business Overview

13.6.5 Hitachi Aloka Latest Developments

13.7 Bertin Instruments

13.7.1 Bertin Instruments Company Information

13.7.2 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Offered

13.7.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bertin Instruments Main Business Overview

13.7.5 Bertin Instruments Latest Developments

13.8 Tracerco

13.8.1 Tracerco Company Information

13.8.2 Tracerco Patient In-vivo Dosimetry (IVD) System Product Offered

13.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Tracerco Main Business Overview

13.8.5 Tracerco Latest Developments

13.9 ATOMTEX

13.9.1 ATOMTEX Company Information

13.9.2 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Offered

13.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ATOMTEX Main Business Overview

13.9.5 ATOMTEX Latest Developments

13.10 Panasonic

13.10.1 Panasonic Company Information

13.10.2 Panasonic Patient In-vivo Dosimetry (IVD) System Product Offered

13.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Panasonic Main Business Overview

13.10.5 Panasonic Latest Developments

13.11 Polimaster

13.11.1 Polimaster Company Information

13.11.2 Polimaster Patient In-vivo Dosimetry (IVD) System Product Offered

13.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Polimaster Main Business Overview

13.11.5 Polimaster Latest Developments

13.12 Renri

13.12.1 Renri Company Information

13.12.2 Renri Patient In-vivo Dosimetry (IVD) System Product Offered

13.12.3 Renri Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Renri Main Business Overview

13.12.5 Renri Latest Developments

13.13 RadPro International GmbH

13.13.1 RadPro International GmbH Company Information

13.13.2 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Offered

13.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 RadPro International GmbH Main Business Overview

13.13.5 RadPro International GmbH Latest Developments

13.14 Ludlum Measurements

13.14.1 Ludlum Measurements Company Information

13.14.2 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Offered

13.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Ludlum Measurements Main Business Overview

13.14.5 Ludlum Measurements Latest Developments

13.15 XZ LAB

13.15.1 XZ LAB Company Information

13.15.2 XZ LAB Patient In-vivo Dosimetry (IVD) System Product Offered

13.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 XZ LAB Main Business Overview

13.15.5 XZ LAB Latest Developments

14 Research Findings and Conclusion

Table 1. Patient In-vivo Dosimetry (IVD) System Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Patient In-vivo Dosimetry (IVD) System Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Portable

Table 4. Major Players of Fixed

Table 5. Global Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)

Table 6. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

Table 7. Global Patient In-vivo Dosimetry (IVD) System Revenue by Type (2017-2022) & ($ million)

Table 8. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2017-2022)

Table 9. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)

Table 11. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Table 12. Global Patient In-vivo Dosimetry (IVD) System Revenue by Application (2017-2022)

Table 13. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2017-2022)

Table 14. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Patient In-vivo Dosimetry (IVD) System Sales by Company (2020-2022) & (K Units)

Table 16. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Company (2020-2022)

Table 17. Global Patient In-vivo Dosimetry (IVD) System Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company (2020-2022)

Table 19. Global Patient In-vivo Dosimetry (IVD) System Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Patient In-vivo Dosimetry (IVD) System Producing Area Distribution and Sales Area

Table 21. Players Patient In-vivo Dosimetry (IVD) System Products Offered

Table 22. Patient In-vivo Dosimetry (IVD) System Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Patient In-vivo Dosimetry (IVD) System Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Geographic Region (2017-2022)

Table 27. Global Patient In-vivo Dosimetry (IVD) System Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Patient In-vivo Dosimetry (IVD) System Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country/Region (2017-2022)

Table 31. Global Patient In-vivo Dosimetry (IVD) System Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)

Table 34. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2022)

Table 35. Americas Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2022)

Table 37. Americas Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)

Table 38. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

Table 39. Americas Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)

Table 40. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Table 41. APAC Patient In-vivo Dosimetry (IVD) System Sales by Region (2017-2022) & (K Units)

Table 42. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2022)

Table 43. APAC Patient In-vivo Dosimetry (IVD) System Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2017-2022)

Table 45. APAC Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)

Table 46. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

Table 47. APAC Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)

Table 48. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Table 49. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)

Table 50. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2022)

Table 51. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2022)

Table 53. Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)

Table 54. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

Table 55. Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)

Table 56. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Patient In-vivo Dosimetry (IVD) System

Table 66. Key Market Challenges & Risks of Patient In-vivo Dosimetry (IVD) System

Table 67. Key Industry Trends of Patient In-vivo Dosimetry (IVD) System

Table 68. Patient In-vivo Dosimetry (IVD) System Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Patient In-vivo Dosimetry (IVD) System Distributors List

Table 71. Patient In-vivo Dosimetry (IVD) System Customer List

Table 72. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Patient In-vivo Dosimetry (IVD) System Sales Market Forecast by Region

Table 74. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Patient In-vivo Dosimetry (IVD) System Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Application (2023-2028)

Table 92. Landauer Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 93. Landauer Patient In-vivo Dosimetry (IVD) System Product Offered

Table 94. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Landauer Main Business

Table 96. Landauer Latest Developments

Table 97. Chiyoda Technol Corporation Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 98. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Offered

Table 99. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Chiyoda Technol Corporation Main Business

Table 101. Chiyoda Technol Corporation Latest Developments

Table 102. Mirion Technologies Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 103. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Offered

Table 104. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Mirion Technologies Main Business

Table 106. Mirion Technologies Latest Developments

Table 107. Thermo Fisher Scientific Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 108. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Offered

Table 109. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Thermo Fisher Scientific Main Business

Table 111. Thermo Fisher Scientific Latest Developments

Table 112. Fuji Electric Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 113. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Offered

Table 114. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Fuji Electric Main Business

Table 116. Fuji Electric Latest Developments

Table 117. Hitachi Aloka Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 118. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Offered

Table 119. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Hitachi Aloka Main Business

Table 121. Hitachi Aloka Latest Developments

Table 122. Bertin Instruments Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 123. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Offered

Table 124. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Bertin Instruments Main Business

Table 126. Bertin Instruments Latest Developments

Table 127. Tracerco Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 128. Tracerco Patient In-vivo Dosimetry (IVD) System Product Offered

Table 129. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Tracerco Main Business

Table 131. Tracerco Latest Developments

Table 132. ATOMTEX Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 133. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Offered

Table 134. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. ATOMTEX Main Business

Table 136. ATOMTEX Latest Developments

Table 137. Panasonic Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 138. Panasonic Patient In-vivo Dosimetry (IVD) System Product Offered

Table 139. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Panasonic Main Business

Table 141. Panasonic Latest Developments

Table 142. Polimaster Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 143. Polimaster Patient In-vivo Dosimetry (IVD) System Product Offered

Table 144. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Polimaster Main Business

Table 146. Polimaster Latest Developments

Table 147. Renri Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 148. Renri Patient In-vivo Dosimetry (IVD) System Product Offered

Table 149. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Renri Main Business

Table 151. Renri Latest Developments

Table 152. RadPro International GmbH Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 153. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Offered

Table 154. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. RadPro International GmbH Main Business

Table 156. RadPro International GmbH Latest Developments

Table 157. Ludlum Measurements Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 158. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Offered

Table 159. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Ludlum Measurements Main Business

Table 161. Ludlum Measurements Latest Developments

Table 162. XZ LAB Basic Information, Patient In-vivo Dosimetry (IVD) System Manufacturing Base, Sales Area and Its Competitors

Table 163. XZ LAB Patient In-vivo Dosimetry (IVD) System Product Offered

Table 164. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. XZ LAB Main Business

Table 166. XZ LAB Latest Developments

List of Figures

Figure 1. Picture of Patient In-vivo Dosimetry (IVD) System

Figure 2. Patient In-vivo Dosimetry (IVD) System Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Patient In-vivo Dosimetry (IVD) System Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Patient In-vivo Dosimetry (IVD) System Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Portable

Figure 10. Product Picture of Fixed

Figure 11. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type in 2021

Figure 12. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2017-2022)

Figure 13. Patient In-vivo Dosimetry (IVD) System Consumed in Medical

Figure 14. Global Patient In-vivo Dosimetry (IVD) System Market: Medical (2017-2022) & (K Units)

Figure 15. Patient In-vivo Dosimetry (IVD) System Consumed in Scientific Research

Figure 16. Global Patient In-vivo Dosimetry (IVD) System Market: Scientific Research (2017-2022) & (K Units)

Figure 17. Patient In-vivo Dosimetry (IVD) System Consumed in Others

Figure 18. Global Patient In-vivo Dosimetry (IVD) System Market: Others (2017-2022) & (K Units)

Figure 19. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2017-2022)

Figure 20. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application in 2021

Figure 21. Patient In-vivo Dosimetry (IVD) System Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Company in 2021

Figure 23. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Geographic Region in 2021

Figure 25. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2017-2022)

Figure 26. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country/Region in 2021

Figure 27. Americas Patient In-vivo Dosimetry (IVD) System Sales 2017-2022 (K Units)

Figure 28. Americas Patient In-vivo Dosimetry (IVD) System Revenue 2017-2022 ($ Millions)

Figure 29. APAC Patient In-vivo Dosimetry (IVD) System Sales 2017-2022 (K Units)

Figure 30. APAC Patient In-vivo Dosimetry (IVD) System Revenue 2017-2022 ($ Millions)

Figure 31. Europe Patient In-vivo Dosimetry (IVD) System Sales 2017-2022 (K Units)

Figure 32. Europe Patient In-vivo Dosimetry (IVD) System Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue 2017-2022 ($ Millions)

Figure 35. Americas Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2021

Figure 36. Americas Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2021

Figure 37. United States Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region in 2021

Figure 42. APAC Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Regions in 2021

Figure 43. China Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2021

Figure 50. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2021

Figure 51. Germany Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country in 2021

Figure 58. Egypt Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Patient In-vivo Dosimetry (IVD) System Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Patient In-vivo Dosimetry (IVD) System in 2021

Figure 64. Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System

Figure 65. Industry Chain Structure of Patient In-vivo Dosimetry (IVD) System

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles